BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/16/2014 3:53:00 PM | Browse: 567 | Download: 549
Publication Name World Journal of Gastroenterology
Manuscript ID 7978
Country/Territory Germany
2013-12-10 18:52
Peer-Review Started
2013-12-11 11:30
To Make the First Decision
2014-01-24 12:26
Return for Revision
2014-01-25 15:14
Second Decision
2014-06-13 15:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-13 16:17
Articles in Press
2014-06-13 16:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-09-22 09:41
Publish the Manuscript Online
2014-10-16 15:53
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title Proteomic and metabolic prediction of response to therapy in gastric cancer
Manuscript Source Invited Manuscript
All Author List Michaela Aichler, Birgit Luber, Florian Lordick and Axel Walch
Funding Agency and Grant Number
Funding Agency Grant Number
Ministry of Education and Research of the Federal Republic of Germany 0315508A
Ministry of Education and Research of the Federal Republic of Germany 01IB10004E (to AW)
Ministry of Education and Research of the Federal Republic of Germany SYS-Stomach (to BL, FL and AW)
Deutsche Forschungsgemeinschaft HO 1258/3-1
Deutsche Forschungsgemeinschaft SFB 824 TP Z02
Deutsche Forschungsgemeinschaft WA 1656/3-1 (to AW)
Corresponding author Axel Walch, MD, Professor, Research Unit Analytical Pathology, Institute of Pathology, Helmholtz Zentrum München, German Research Centre for Environmental Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany. axel.walch@helmholtz-muenchen.de
Keywords Gastric cancer; Therapy; Response prediction; positron emission tomography; matrix-assisted laser desorption-ionization
Core Tip The prognosis of patients diagnosed with gastric cancer is still poor. Cytotoxic treatment and targeted therapies have improved the prognosis of patients. However, patients do not benefit equally from these treatment options. The ability to predict whether patients will respond to specific therapies would be of particular value and would allow for stratifying patients for personalized treatment strategies. In this review, we discuss the status of targeted therapies for gastric cancer, as well as proteomic and metabolic methods for investigating biomarkers for therapy response prediction in gastric cancer.
Publish Date 2014-10-16 15:53
Citation Aichler M, Luber B, Lordick F, Walch A. Proteomic and metabolic prediction of response to therapy in gastric cancer. World J Gastroenterol 2014; 20(38): 13648-13657
Url http://www.wjgnet.com/1007-9327/full/v20/i38/13648.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i38.13648
Full Article (PDF) WJG-20-13648.pdf
Full Article (Word) WJG-20-13648.doc
Manuscript File 7978-Review.docx
Answering Reviewers 7978-Answering reviewers.pdf
Copyright License Agreement 7978-Copyright assignment.pdf
Peer-review Report 7978-Peer reivew(s).pdf
Scientific Misconduct Check 7978-CrossCheck.jpg
Scientific Editor Work List 7978-Scientific editor work list.pdf